Published by Josh White on 5th January 2022
(Sharecast News) - Organ transplant clinical diagnosis developer Verici Dx announced a collaboration with Nasdaq-listed Illumina on Wednesday, to expedite the operational launch of data analysis processing and the predictive artificial intelligence component of its products using early access to Illumina's new software platform ICA.